Rainer Storb Selected Research

Cyclosporine (Ciclosporin)

1/2021	Long-term Outcomes with Nonmyeloablative HLA-Identical Related Hematopoietic Cell Transplantation Using Tacrolimus and Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis.
1/2020	Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors.
8/2019	Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
3/2012	Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation.
10/2010	Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.
5/2008	Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
12/2007	HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.
9/2007	Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
6/2007	Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression.
6/2006	Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rainer Storb Research Topics

Disease

61	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2002
55	Neoplasms (Cancer) 01/2022 - 01/2002
45	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2002
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2002
15	Bronchiolitis Obliterans Syndrome 01/2020 - 02/2002
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 01/2002
10	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 01/2002
10	Infections 01/2020 - 01/2002
10	Leukemia 01/2020 - 01/2005
7	Hematologic Diseases (Blood Diseases) 12/2020 - 01/2003
7	Lymphoma (Lymphomas) 01/2018 - 01/2006
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 06/2005
5	Multiple Myeloma 01/2019 - 11/2003
5	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 04/2013 - 12/2004
5	Muscular Dystrophies (Muscular Dystrophy) 10/2012 - 12/2004
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2007 - 11/2003
4	Hemolysis 01/2019 - 02/2002
4	Primary Myelofibrosis (Myelosclerosis) 03/2012 - 12/2003
4	Pathologic Complete Response 03/2007 - 10/2002
4	Renal Cell Carcinoma (Grawitz Tumor) 10/2005 - 01/2003
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2019 - 09/2005
3	Neutropenia 05/2013 - 07/2008
3	Lymphopenia (Lymphocytopenia) 05/2013 - 04/2002
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2011 - 07/2003
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2011 - 01/2003
3	Fibrosis (Cirrhosis) 08/2007 - 11/2003
3	Systemic Scleroderma (Systemic Sclerosis) 08/2007 - 12/2004
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2022 - 07/2006
2	Renal Insufficiency (Renal Failure) 01/2020 - 05/2008
2	Disease Progression 01/2020 - 11/2017
2	Viremia 01/2020 - 03/2002
2	Jaundice (Icterus) 01/2020 - 01/2004
2	Invasive Fungal Infections 10/2018 - 03/2009
2	Ascites 11/2015 - 07/2002
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2015 - 12/2004
2	Residual Neoplasm 02/2015 - 08/2011
2	Chromosome Aberrations (Chromosome Abnormalities) 08/2012 - 12/2007
2	Thrombocytopenia (Thrombopenia) 12/2011 - 05/2003
2	Hemophilia B (Haemophilia B) 01/2011 - 03/2010
2	T-Cell Lymphoma (Lymphoma, T Cell) 07/2010 - 03/2006
2	Virus Diseases (Viral Diseases) 08/2009 - 09/2006
2	Acute Kidney Injury (Acute Renal Failure) 03/2008 - 03/2005
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2008 - 07/2006
2	Blast Crisis (Blast Phase) 10/2007 - 04/2005
2	Essential Thrombocythemia 03/2007 - 07/2002
2	Polycythemia Vera 03/2007 - 07/2002
2	Multiple Sclerosis 12/2004 - 10/2003
2	Cytomegalovirus Infections (Inclusion Disease) 11/2003 - 03/2002

Drug/Important Bio-Agent (IBA)

25	fludarabineIBA 01/2021 - 01/2003
19	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 03/2002
18	AntigensIBA 12/2020 - 03/2002
11	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 03/2002
11	Methotrexate (Mexate)FDA LinkGeneric 12/2014 - 07/2003
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2016 - 08/2002
7	HLA Antigens (Human Leukocyte Antigens)IBA 10/2014 - 11/2003
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 05/2008
5	Sirolimus (Rapamycin)FDA Link 01/2021 - 05/2008
5	Calcineurin InhibitorsIBA 01/2021 - 05/2008
5	SteroidsIBA 09/2017 - 01/2002
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2016 - 12/2005
4	Rituximab (Mabthera)FDA Link 10/2020 - 11/2004
4	Prednisone (Sone)FDA LinkGeneric 01/2020 - 07/2002
4	DystrophinIBA 08/2012 - 12/2004
4	Busulfan (Busulfex)FDA Link 05/2006 - 01/2002
3	Monoclonal AntibodiesIBA 01/2018 - 11/2004
3	TEMPOIBA 01/2015 - 12/2004
3	Capsid Proteins (Capsid Protein)IBA 01/2011 - 03/2010
2	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2015
2	Clofarabine (Clolar)FDA Link 01/2021 - 01/2020
2	AntibodiesIBA 01/2018 - 12/2004
2	Inducible T-Cell Co-Stimulator ProteinIBA 01/2018 - 07/2013
2	RNA (Ribonucleic Acid)IBA 11/2016 - 10/2008
2	Minor Histocompatibility AntigensIBA 10/2015 - 12/2004
2	VaccinesIBA 10/2015 - 03/2007
2	LigandsIBA 10/2012 - 05/2009
2	Pharmaceutical PreparationsIBA 12/2011 - 09/2006
2	Imatinib Mesylate (Gleevec)FDA Link 08/2011 - 11/2004
2	Alkylating AgentsIBA 07/2010 - 12/2007
2	GlucocorticoidsIBA 03/2009 - 04/2002
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 06/2007 - 09/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2006 - 03/2006
2	Isoantigens (Alloantigen)IBA 08/2004 - 02/2003

Therapy/Procedure

126	Cell Transplantation 01/2022 - 07/2003
45	Therapeutics 01/2021 - 01/2002
44	Transplantation 01/2022 - 01/2002
19	Hematopoietic Stem Cell Transplantation 11/2016 - 01/2002
16	Stem Cell Transplantation 12/2022 - 01/2002
11	Homologous Transplantation 10/2018 - 01/2002
9	Drug Therapy (Chemotherapy) 02/2015 - 10/2002
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 07/2002
4	Immunotherapy 01/2020 - 08/2003
3	Chemoradiotherapy 01/2005 - 11/2004
3	Radiotherapy 01/2005 - 01/2003
2	Radioimmunotherapy 11/2015 - 07/2006
2	Aftercare (After-Treatment) 10/2015 - 10/2002
2	Consolidation Chemotherapy 02/2015 - 03/2007
2	Organ Transplantation 09/2012 - 10/2002
2	Contraindications 06/2007 - 08/2002
2	Autologous Transplantation 07/2006 - 01/2005
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/2003 - 07/2002